Send us a Message

*
*
*
*

Guildford, UK

ID Business Solutions Ltd.

2 Occam Court
Surrey Research Park
Guildford, Surrey
GU2 7QB
United Kingdom

Tel: +44 1483 595 000
Fax: +44 1483 595 001

London, UK

ID Business Solutions Ltd.

4th Floor, Pembroke Building
Kensington Village
Avonmore Road
London, W14 8DG
United Kingdom

Tel: +44 207 565 8620
Fax: +44 207 565 8700

Paris, France

ID Business Solutions Ltd.

18 Rue Pasquier,
Paris, 75008
France

Tel: +33 01 78 41 44 46

Alameda, California

ID Business Solutions Inc.

1301 Marina Village Parkway
Suite 320,
Alameda, CA 94501

Tel: +1 510 814 4900
Fax: +1 510 814 4910

Bridgewater, New Jersey

ID Business Solutions Inc.

750 US Highway 202,
Suite 200,
Bridgewater, NJ 08807

Tel: +1 908 429 2900
Fax: +1 908 429 2901

Burlington, Massachusetts

ID Business Solutions Inc.

25 Burlington Mall Road
1st Floor, Suite #107
Burlington, MA 01803

Tel: +1 781 272 3355
Fax: +1 781 272 3377

Tokyo, Japan

ID Business Solutions (Japan)

Shibuya Mark City W22F
1-12-1 Dogenzaka Shibuya-ku Tokyo
150-0043 Japan

Tel: +81 3 4360 5344

Bangalore, India

Tel: +91-990-0064-922
+91-080-2587-0336

IDBS Offices Worldwide

Close

Biomarkers and Diagnostics

Secure storage, comprehensive analysis and flexible reporting of all biomarker data in one framework

IDBS provides a powerful and flexible foundation to search, analyze, view and compare clinical, LIMS and experimental data for biomarker and diagnostics research. Based on IDBS’ E-WorkBook this unified system supports any experimental workflow including GWAS, Next Generation Sequencing, gene expression, microarrays, proteomics and image analysis.

By providing a central, secure, scalable and searchable solution, organizations can improve their scientific productivity by ensuring experiments are not repeated, relevant data can be easily found and reports can be generated quickly.

  • Capture intellectual property and key decision points to improve research audit trail and reporting of discoveries
  • Boost knowledge sharing and reuse of data across an organization
  • Identify subject cohorts easily and stratify against putative biomarker properties and endpoints across multiple studies
  • Discover new insights into disease development and progression
  • Mine past clinical data for new insights and possible biomarkers
  • Qualify putative biomarkers using external sources and third party data
  • Reduce the burden of paper notebooks/paper trails and use of Excel to track results
  • Validate to comply with GxP and 21 CFR Part 11